Topics

"Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on dosage, safety and efficacy.[1][2] They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial—their approval does not mean the therapy is 'safe' or effective, only that the trial may be conducted."

Source:  https://en.wikipedia.org/wiki/Clinical_trial 

vaccines
2.4 Nonclinical Overview AZD1222
2.5 Clinical Overview: AZD1222 Marketing Authorisation Application - Primary Analysis (Data Cut-off 07 December 2020)
5.3.6 Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received through 28-FEB-2021
Anti-science case study: COVID-19 vaccines’ effectiveness and safety exaggerated
BMF Investigation: FDA oversight of clinical trials is “grossly inadequate,” say experts
CBER Plans for Monitoring COVID-19 Vaccine Safety and Effectivenes
Court documents and clinical-trial documents for Pfizer, Inc. and Moderna, Inc.
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room
Covid-19 vaccines and treatments: we must have raw data, now
Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
Does the FDA think these data justify the first full approval of a covid-19 vaccine?
Down The Covid-19 Rabbit Hole: Independent Scientists And Physicians Unmask The Pandemic
Dr. Peter McCullough presentation at 78th Annual Meeting of Association of American Physicians and Surgeons (AAPS)
Dr. Scott Youngblood presentation to the San Diego City Council
Expedited COVID-19 vaccine trials: a rat-race with challenges and ethical issues
Fact Sheet for Recipients and Caregivers - Emergency Use Authorization (EUA) of the Pfizer-Biontech COVID-19 Vaccine to Prevent Coronavirus
Have People Been Given the Wrong Vaccine?
How Bad is My Batch? Batch codes and associated deaths, disabilities and illnesses for Covid 19 Vaccines
How the adverse effect counting window affected vaccine safety calculations in randomised trials of COVID‐19 vaccines
Injections from Hell?
Interim position paper: considerations regarding proof of COVID-19 vaccination for international travelers
Johnson & Johnson clinical trial: A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants
Kansas AG sues Pfizer for misleading Kansans on COVID vaccine
Large-scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
Moderna clinical trial: A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19
Moderna trial paper: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
mRNA Vaccine Toxicity
New VAERS analysis reveals hundreds of serious adverse events that the CDC and FDA never told us about
News release: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
Panel of doctors in Nashville, Tennessee
Pfizer clinical trial: Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness Study
Pfizer director admits vaccine was never tested on preventing transmission
Pfizer trial paper: Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Pfizer/BioNTech’s COVID-19 modRNA Vaccines: Dangerous Genetic Mechanism of Action Released before Sufficient Preclinical Testing
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults by AstraZeneca
Plaintiffs Motion for Preliminary Injunction: America’s Frontline Doctors, et al., vs. Xavier Becerra, Secretary of the US Department of Health and Human Services
Questions for a Covid-19 Commission
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
Session 86 of the Corona Investigative Committee
Sources of bias in observational studies of covid-19 vaccine effectiveness
Statement by Dr. Aditi Bhargava: 'These Are Not Normal Vaccines'
Statement by Dr. Robert Kaplan
Statement by Peter Doshi
Summary Basis for Regulatory Action
Testimony of Dr. Aditi Bhargava
The Pfizer Inoculations For COVID-19 – More Harm Than Good
539